Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S17 pseudogene 8 (RPS17P8) is a non-coding, processed pseudogene in the human genome, related by sequence to the protein-coding ribosomal protein S17 gene. It arose from gene duplication events and does not produce functional protein. It is not involved in cellular biology, disease, or pharmacology and is not recognized as a druggable target or clinically relevant gene. Canonical protein-coding ribosomal genes like RPS17 have critical biological functions in ribosome assembly and genetic disorders (e.g., Diamond-Blackfan anemia); however, RPS17P8 does not share these properties.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S17 pseudogene 8 (RPS17P8).